Therapy insight: Management of hepatorenal syndrome - PubMed

Review

Therapy insight: Management of hepatorenal syndrome

Andrés Cárdenas et al. Nat Clin Pract Gastroenterol Hepatol. 2006 Jun.

Abstract

Hepatorenal syndrome (HRS), a feared complication of advanced cirrhosis, is characterized by functional renal failure, secondary to renal vasoconstriction in the absence of underlying kidney pathology. Extreme underfilling of the arterial circulation, caused by arterial vasodilation of the splanchnic circulation, activates vasoconstrictor systems, which lead to intense renal vasoconstriction and HRS. Factors predictive for the development of HRS include intense urinary sodium retention, dilutional hyponatremia, low blood pressure, decreased cardiac output, and increased activity of systemic vasoconstrictors. The prognosis for patients with HRS is extremely poor, especially for those with the acute, progressive (type 1) form. Liver transplantation is the best treatment for suitable candidates and should always be the management option considered first. Pharmacologic therapies are aimed at improving renal function to enable patients to survive until transplantation is possible. These therapies are based on plasma expansion with albumin, combined with the use of either vasopressin analogs or alpha-adrenergic agonists. Other nonpharmacologic therapies, such as transjugular intrahepatic portosystemic shunts and albumin dialysis show promise, but experience with these treatments is limited. For prevention of HRS, albumin infusion is recommended in patients with spontaneous bacterial peritonitis, and pentoxifylline treatment is recommended in patients with acute alcoholic hepatitis.

Similar articles

• Hepatorenal syndrome: a dreaded complication of end-stage liver disease.

  Cárdenas A. Cárdenas A. Am J Gastroenterol. 2005 Feb;100(2):460-7. doi: 10.1111/j.1572-0241.2005.40952.x. Am J Gastroenterol. 2005. PMID: 15667508 Review.

• New treatments of hepatorenal syndrome.

  Arroyo V, Terra C, Ginès P. Arroyo V, et al. Semin Liver Dis. 2006 Aug;26(3):254-64. doi: 10.1055/s-2006-947293. Semin Liver Dis. 2006. PMID: 16850375 Review.

• Diagnosis and treatment of hepatorenal syndrome.

  Ginès P. Ginès P. Baillieres Best Pract Res Clin Gastroenterol. 2000 Dec;14(6):945-57. doi: 10.1053/bega.2000.0140. Baillieres Best Pract Res Clin Gastroenterol. 2000. PMID: 11139348 Review.

• Treatment of hepatorenal syndrome.

  Kiser TH, Maclaren R, Fish DN. Kiser TH, et al. Pharmacotherapy. 2009 Oct;29(10):1196-211. doi: 10.1592/phco.29.10.1196. Pharmacotherapy. 2009. PMID: 19792993 Review.

• Recent advances in hepatorenal syndrome.

  Arroyo V, Torre A, Guevara M. Arroyo V, et al. Trop Gastroenterol. 2005 Jan-Mar;26(1):13-20. Trop Gastroenterol. 2005. PMID: 15974232 Review.

Cited by

• Outcomes of liver transplantation in patients with hepatorenal syndrome.

  Modi RM, Patel N, Metwally SN, Mumtaz K. Modi RM, et al. World J Hepatol. 2016 Aug 28;8(24):999-1011. doi: 10.4254/wjh.v8.i24.999. World J Hepatol. 2016. PMID: 27648152 Free PMC article. Review.

• Development of hepatorenal syndrome in bile duct ligated rats.

  Pereira RM, dos Santos RA, Oliveira EA, Leite VH, Dias FL, Rezende AS, Costa LP, Barcelos LS, Teixeira MM, Simoes e Silva AC. Pereira RM, et al. World J Gastroenterol. 2008 Jul 28;14(28):4505-11. doi: 10.3748/wjg.14.4505. World J Gastroenterol. 2008. PMID: 18680230 Free PMC article.

• Perioperative Evolution of Sodium Levels in Cirrhotic Patients Undergoing Liver Transplantation: An Observational Cohort and Literature Review.

  Zamberg I, Maillard J, Assouline B, Tomala S, Keli-Barcelos G, Aldenkortt F, Mavrakanas T, Andres A, Schiffer E. Zamberg I, et al. Hepat Med. 2021 Aug 7;13:71-82. doi: 10.2147/HMER.S320127. eCollection 2021. Hepat Med. 2021. PMID: 34393524 Free PMC article.

• Recommendations for the use of albumin and immunoglobulins.

  Liumbruno GM, Bennardello F, Lattanzio A, Piccoli P, Rossettias G; Italian Society of Transfusion Medicine and Immunohaematology (SIMTI). Liumbruno GM, et al. Blood Transfus. 2009 Jul;7(3):216-34. doi: 10.2450/2009.0094-09. Blood Transfus. 2009. PMID: 19657486 Free PMC article. No abstract available.

Publication types

MeSH terms

Substances

LinkOut - more resources

• Medical

  • MedlinePlus Health Information